🇺🇸 rhTSH stimulation in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FDA authorised rhTSH stimulation on 30 November 1998

Marketing authorisation

FDA — authorised 30 November 1998

Application: BLA020898
Marketing authorisation holder: GENZYME
Local brand name: THYROGEN
Indication: INJECTABLE — INJECTION
Status: approved

Read official source →

Other Oncology approved in United States

Frequently asked questions

Is rhTSH stimulation approved in United States?

Yes. FDA authorised it on 30 November 1998.

Who is the marketing authorisation holder for rhTSH stimulation in United States?

GENZYME holds the US marketing authorisation.